Healthcare provider profile · identity verified

Thomas J Purgason, MD

Internal Medicine · ARLINGTON, TX · NPI 1831161637

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	483	139
Levothyroxine Sodium	Levothyroxine Sodium	458	108
Prednisone	Prednisone	338	195
Atorvastatin Calcium	Atorvastatin Calcium	309	84
Montelukast Sodium	Montelukast Sodium	264	77
Amlodipine Besylate	Amlodipine Besylate	254	73
Metformin Hcl	Metformin Hcl	236	71
Losartan Potassium	Losartan Potassium	225	65
Alprazolam	Alprazolam	211	46
Metoprolol Succinate	Metoprolol Succinate	207	58
Omeprazole	Omeprazole	200	54
Tramadol Hcl	Tramadol Hcl	190	45
Gabapentin	Gabapentin	181	55
Ezetimibe	Ezetimibe	172	54
Potassium Chloride	Potassium Chloride	155	55
Allopurinol	Allopurinol	153	42
Acetaminophen-Codeine	Acetaminophen With Codeine	148	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	143	45
Pantoprazole Sodium	Pantoprazole Sodium	142	42
Cefuroxime	Cefuroxime Axetil	141	103
Trazodone Hcl	Trazodone Hcl	138	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	136	46
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	133	41
Tamsulosin Hcl	Tamsulosin Hcl	128	35
Hydrochlorothiazide	Hydrochlorothiazide	120	36
Eliquis	Apixaban	116	30
Furosemide	Furosemide	111	38
Escitalopram Oxalate	Escitalopram Oxalate	110	32
Simvastatin	Simvastatin	101	28
Pioglitazone Hcl	Pioglitazone Hcl	95	29
Ciprofloxacin Hcl	Ciprofloxacin Hcl	89	76
Glimepiride	Glimepiride	86	27
Zolpidem Tartrate	Zolpidem Tartrate	80	15
Memantine Hcl	Memantine Hcl	78	15
Albuterol Sulfate Hfa	Albuterol Sulfate	77	39
Synthroid	Levothyroxine Sodium	74	18
Azithromycin	Azithromycin	72	56
Lisinopril	Lisinopril	72	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	71	54
Carvedilol	Carvedilol	71	20
Celecoxib	Celecoxib	70	24
Ozempic	Semaglutide	69	suppressed
Pravastatin Sodium	Pravastatin Sodium	68	19
Famotidine	Famotidine	67	19
Venlafaxine Hcl Er	Venlafaxine Hcl	67	19
Estradiol	Estradiol	64	17
Meloxicam	Meloxicam	61	18
Clonazepam	Clonazepam	58	suppressed
Duloxetine Hcl	Duloxetine Hcl	55	14
Cephalexin	Cephalexin	53	42
Citalopram Hbr	Citalopram Hydrobromide	52	suppressed
Clopidogrel	Clopidogrel Bisulfate	49	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	suppressed
Spironolactone	Spironolactone	48	17
Donepezil Hcl	Donepezil Hcl	47	13
Fluconazole	Fluconazole	46	30
Ropinirole Hcl	Ropinirole Hcl	46	12
Nitrofurantoin	Nitrofurantoin Macrocrystal	44	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	42	11
Levofloxacin	Levofloxacin	42	32
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	41	suppressed
Meclizine Hcl	Meclizine Hcl	38	18
Paxlovid	Nirmatrelvir/Ritonavir	38	38
Sertraline Hcl	Sertraline Hcl	38	suppressed
Solifenacin Succinate	Solifenacin Succinate	38	12
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	37	suppressed
Nebivolol Hcl	Nebivolol Hcl	37	11
Ondansetron Odt	Ondansetron	37	26
Ibandronate Sodium	Ibandronate Sodium	36	12
Finasteride	Finasteride	34	suppressed
Clonidine Hcl	Clonidine Hcl	33	12
Fenofibrate	Fenofibrate,micronized	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	26
Diazepam	Diazepam	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Metformin Hcl Er	Metformin Hcl	29	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	29	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Temazepam	Temazepam	28	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	18
Valacyclovir	Valacyclovir Hcl	27	suppressed
Acyclovir	Acyclovir	26	17
Dutasteride	Dutasteride	26	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Metronidazole	Metronidazole	26	23
Ramipril	Ramipril	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Colestipol Hcl	Colestipol Hcl	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Atenolol	Atenolol	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Methocarbamol	Methocarbamol	24	14
Naproxen	Naproxen	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Dilt-Xr	Diltiazem Hcl	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Tobramycin	Tobramycin	21	16
Trulicity	Dulaglutide	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Valsartan	Valsartan	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	14
Eszopiclone	Eszopiclone	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	13
Torsemide	Torsemide	16	suppressed
Bystolic	Nebivolol Hcl	15	suppressed
Cefixime	Cefixime	15	13
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Sotalol	Sotalol Hcl	15	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	11
Irbesartan	Irbesartan	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Np Thyroid	Thyroid,pork	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Betamethasone Valerate	Betamethasone Valerate	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Prolia	Denosumab	11	suppressed
Ssd	Silver Sulfadiazine	11	suppressed
Ursodiol	Ursodiol	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error